Variable | Statistic N = 1336 |
---|---|
Setting | |
Office | 802 (60%) |
(US only) Outpatient Community Health Clinic | 75 (6%) |
(France only) Centre Medical Psychologique | 53 (4%) |
Hospital Outpatient Clinic | 351 (26%) |
Telemedicine | 12 (1%) |
Patient’s Home | 23 (2%) |
Day Clinic | 19 (1%) |
Other | 1 (< 1%) |
Length of MDD diagnosis | |
< 1 month | 88 (7%) |
1–3 months | 174 (13%) |
4–6 months | 180 (14%) |
7–9 months | 65 (5%) |
10–12 months | 211 (16%) |
2–5 years | 370 (28%) |
6 + years | 248 (19%) |
Current treatment | |
SSRI | 800 (60%) |
SNRI | 320 (24%) |
MAOI | 7 (< 1%) |
TCA | 49 (4%) |
Other antidepressant | 295 (22%) |
Anxiolytic | 239 (18%) |
Antipsychotic | 243 (18%) |
Hypnotic | 76 (6%) |
Other treatment for depression | 69 (5%) |
Mean current ADT duration by treatment class (weeks) | |
SSRI | 45.4 |
SNRI | 48.7 |
MAOI | 22.0 |
TCA | 106.8 |
Other antidepressant | 38.9 |
Number of current classes of prescription treatments for depression (this episode); n (%) | |
0 | 6 (< 1%) |
1 | 755 (57%) |
2 | 397 (30%) |
3 | 145 (11%) |
4 | 28 (2%) |
5 + | 5 (< 1%) |
Mean number | 1.6 |
Level of functioning (mean SDS scores) | |
SDS Mean score | 5.1 |
Work domain | 6.0 |
Social domain | 4.7 |
Home domain | 4.5 |
PHQ-9 score (mean) | 6.2 |
Clinical global impression of change in depression since onset of episode to current visit | |
Very much worse | 5 (< 1%) |
Much worse | 63 (5%) |
Minimally worse | 113 (9%) |
No change | 248 (19%) |
Minimally improved | 413 (31%) |
Much improved | 400 (30%) |
Very much improved | 94 (7%) |